MM cancer stem cell-like cells (CSCs) expressed significantly higher levels of CS1 than any other cell type, making them especially vulnerable to being eradicated by CS1-CAR NK cells [100]. The gene discussed is SLAMF7; the disease is Miyoshi myopathy.